Dipsogenic factors operating in chronic uremics on maintenance hemodialysis.
Thirst and hyperdipsia of anuric chronic uremics on maintenance hemodialysis and the possible dipsogenic factors were studied. Exaggerated thirst was present in 213 (86%) of the 247 studied patients. It usually started 4-6 h after the end of the dialysis session, persisted during the whole interdialytic period and often disappeared during the subsequent dialysis. Hyperdipsia, as indicated by the high body weight gain (> 4%) in the interdialytic periods, was present in 33.6% of patients. The highest rate of increase of body weight occurred in the first hours following the end of dialysis sessions. Hypernatremia, potassium depletion, increasing plasma urea levels and elevated plasma angiotensin II levels were considered as the possible dipsogenic factors of a nonpsychic nature. Sodium is certainly of paramount importance for its obliged extracellular position, and when sodium intake is elevated, hypernatremia is very likely the cause of exaggerated thirst and weight gain in patients on hemodialysis. Potassium depletion may cause thirst in animals, but this condition is extremely rare in patients on maintenance hemodialysis, who often accumulate it. In these patients it is, therefore, unlikely that potassium depletion is a dipsogenic factor. Increasing serum urea levels exert an evident dipsogenic effect in anephric rats and urea, when infused into normal volunteers, stimulates thirst. The extracellular urea levels in the interdialytic period are certainly higher than the intracellular ones, as a consequence of its continuous accumulation, and this creates an osmotic gradient with a dipsogenic effect. When this gradient is reversed, following hemodialysis (which removes first the extracellular urea), the dipsogenic effect disappears.(ABSTRACT TRUNCATED AT 250 WORDS)
Institute of Clinica Medica 1, University, Pisa, Italy.
S
S
Giovannetti
G
G
Barsotti
A
A
Cupisti
E
E
Morelli
B
B
Agostini
L
L
Posella
P
P
Gazzetti
L
L
Dani
M
M
Aloisi
A
A
Antonelli
D000328:Adult; D000368:Aged; D000804:Angiotensin II / Q000097:blood; D000818:Animals; D004326:Drinking / Q000502:physiology; D005260:Female; D006801:Humans; D006955:Hypernatremia / Q000503:physiopathology; D008297:Male; D008875:Middle Aged; D011188:Potassium / Q000097:blood; D006435:Renal Dialysis / Q000009:adverse effects*; D013894:Thirst / Q000502:physiology*; D014508:Urea / Q000097:blood; D014511:Uremia / Q000097:blood / Q000503:physiopathology* / Q000628:therapy; D015430:Weight Gain / Q000502:physiology
D000804:Angiotensin II; D014508:Urea; D011188:Potassium